DCTH Total Utang marang Modal Delcath

DCTH (Delcath Systems) - tandha merek perusahaan

This chart of separate_debt_total_eq quotes for Delcath Systems, Inc. (DCTH) is 0.02. The business relies on creating a closed interventional oncology environment using CHEMOSAT, which strictly locks clinics into brand standards. Despite geopolitical risks hindering global testing and deliveries, Delcath Systems, Inc. (DCTH) maintains its first-mover status in liver therapy due to high confidence in HEPZATO.

Rasio Utang marang Ekuitas: delcath.com (DCTH) kanggo 04.07.2022 - 28.10.2026

Rincian metrik komprehensif lan analitis Delcath Corp (DCTH)

- rega lan prakiraan konsensus rega:
Rega saham Delcath Systems|DCTH - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar Delcath Systems|DCTH - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Delcath Systems|DCTH - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku delcath.com|DCTH - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Delcath Systems, Inc.|DCTH - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Delcath Systems, Inc.|DCTH - Kewajiban utang agregat|Utang marang nilai buku Delcath Systems|DCTH - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Delcath Systems
Analisis komprehensif perusahaan:DCTH - Delcath Systems
Sampel barang Delcath Systems, Inc.

Delcath Systems, Inc. (DCTH) implements complex local cancer therapy systems while facing regulatory barriers. This debt-to-equity ratio reflects the proportion of borrowed funds within the financing structure. The metric measures financial leverage by dividing total debt by equity. A low debt load is critical given the high costs associated with rolling out treatment protocols. Investors view this margin of safety as a guarantee of business viability.

Pesaing utama

Total Utang marang Modal ONC|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc.|Total Utang marang Modal RVMD|Total Utang marang Modal AAPG (Ascentage Pharma Corp)|CGON - Utang marang Ekuitas|Rasio Utang marang Ekuitas urogen.com URGN|BCAX: Total Utang marang Modal|PSNL - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ERAS|YMAB (Y-mAbs Corp) - Utang marang Modal|AURA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Candel (CADL)|Accuray (ARAY) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi sellaslifesciences.com (SLS)|Actuate Therapeutics, Inc - Total Utang marang Modal|CTOR - Rasio Total Utang marang Ekuitas|TuHURA - Rasio Total Utang marang Ekuitas|TARA: Total Utang marang Modal|Utang marang Ekuitas Fate Therapeutics FATE|Aadi Bioscience (WHWK) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal TCRX (TScan Therapeutics Inc)|Utang marang Modal Champions Oncology Corp|Total Utang marang Modal XBiotech Inc. XBIT|Rasio Utang marang Ekuitas cel-sci.com (CVM)|OSTX: Total Utang marang Modal|radiopharmtheranostics.com - Utang marang Modal|ARTV - Utang marang Ekuitas|ANL - Utang marang Ekuitas|VERU (Veru Inc.) - Total Utang marang Modal|tempesttx.com (TPST) - Rasio Total Utang marang Ekuitas|XLO (Xilio Therapeutics Inc) - Total Utang marang Modal|Total Utang marang Modal Enochian BioSciences (RENB)|Rasio Total Utang marang Ekuitas Mural Oncology plc|Utang Agregat marang Modal kairospharma.com (KAPA)|Total Utang marang Modal OnKure Therapeutics|GDTC - Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas Curis Corp (CRIS)|APLM: Rasio Kabeh Utang marang Dana Pribadi|Tharimmune Corp - Utang marang Ekuitas|Koefisien Total Utang marang Modal Advanced Biomed|Rasio Total Utang marang Ekuitas GNPX (Genprex, Inc.)|Utang marang Modal CLDI|SBFM (Sunshine Biopharma, Inc.) - Utang marang Ekuitas|Koefisien Total Utang marang Modal xeneticbio.com XBIO|Rasio Total Utang marang Ekuitas Salarius (SLRX)|Utang Agregat marang Modal Kitov Pharma PPBT|AONC (AON) - Total Utang marang Modal|BGNE: Utang marang Modal|CKPT (Checkpoint Therapeutics, Inc.) - Utang marang Ekuitas|ELEV (elevationoncology.com) - Rasio Total Utang marang Ekuitas|ICAD: Utang marang Ekuitas|Koefisien Total Utang marang Modal Ikena (IKNA)|Notable Labs, Ltd. (NTBL) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi viracta.com (VIRX)|Total Utang marang Modal MOR|NAYA Biosciences Inc - Koefisien Total Utang marang Modal|Ascentage Pharma Group Ltd (AAPGV) - Utang marang Ekuitas